Neurophotonics

Defining the boundaries of functional cortical areas is increasingly important for targeted electro-physiology, optical imaging, viral delivery, and circuit manipulation. Intrinsic optical signal imaging (IOSI) provides a rapid and minimally invasive approach for mapping stimulus-evoked cortical activity, but its implementation often requires laboratory-specific combinations of stimulus-generation hardware, experiment-control software, synchronization devices, and data-acquisition systems. These requirements limit accessibility and hinder the use of IOSI as a routine functional mapping tool. Here, we present the Arduino-Based Intrinsic Stimulation System (ABISS), an open-source platform that integrates auditory and visual stimulus generation, trial timing, and image-acquisition triggering into a single programmable device. ABISS generates auditory tone stimuli, VGA-based visual stimuli, and tightly synchronized camera-trigger pulses without requiring a dedicated experiment-control system. Stimulus protocols are also fully modifiable in firmware. Performance was evaluated in auditory and visual cortices of mice. Engineering validation demonstrated accurate stimulus generation and synchronization between stimulus delivery and camera triggering over extended recording sessions. Biological validation showed that ABISS output results in auditory and visual intrinsic signal maps comparable to those obtained using highly specialized or commercial platforms. Together, these findings demonstrate the utility of a low-cost open-source platform for experimental control of intrinsic optical signal imaging. By reducing the technical and financial barriers associated with routine intrinsic optical imaging, ABISS facilitates broader adoption of functional cortical mapping as a tool for improved cortical localization in neuroscience experiments. Significance StatementFunctional cortical mapping is an increasingly important element of neuroscience experimental design as anatomical coordinates alone are often insufficient for defining cortical boundaries in individual animals. Intrinsic optical signal imaging provides an effective solution but traditionally requires specialized hardware, commercial stimulus-generation systems, and laboratory-specific synchronization workflows. We developed ABISS, an inexpensive, open-source platform that integrates auditory and visual stimulus generation with synchronized camera triggering in a single programmable device. ABISS produces functional cortical maps comparable to those obtainable with commercial or specialized systems while substantially reducing hardware complexity and cost. By making intrinsic optical signal imaging more accessible, ABISS lowers the practical barriers for routine functional mapping of the brain and promotes adoption of this important neuroscience technique.

The development of a new integrated operant system was driven by two challenges in behavioral neuroscience: the high cost and technical complexity of commercial rigs, and their limited adaptability across experiments. We developed the NeuroHab, an integrated behavioral arena for high-fidelity operant conditioning and automated data collection in a single unified system. Food and water reward, conditioned-stimulus presentation, and event recording are tied together programmatically with easy-to-install open-source code to facilitate throughput and reproducibility. All behavioral events are processed by internal microcontrollers and logged with <1 ms latency (typical range 56-728 s). This precise timing is critical for integrating the system with two-photon imaging and electrophysiology, enabling real-time alignment of behavior with brain activity. The NeuroHab uses solenoid-actuated, capacitive-sensing Lickports that let an untethered mouse drink from an automated port, and delivers food via the Kravitz Lab FED3. Conditioned stimuli are presented by dedicated buzzer/LED modules. A central controller (the Core) coordinates all modules and logs event timestamps using TTL-low signaling between two microcontrollers, at a maximum recording rate of 16.67 Hz for single-pulse events. We have deployed the NeuroHab in over 50 behavior trials and over 20 sessions alongside a Mini two-photon microscope. At approximately $1,400, easily modified, and compatible with existing analysis tools, the NeuroHab lowers barriers to multimodal behavioral neuroscience. Significance StatementThe study of how neural activity gives rise to behavior depends on operant systems that are both temporally precise and affordable, yet commercial rigs are costly and difficult to adapt across experiments. We introduce the NeuroHab, an integrated, open-source operant platform that unifies reward delivery, conditioned-stimulus presentation, and event logging with sub-millisecond timing (typical latency 56-728 s). Built for approximately $1,400, the system forwards all behavioral timestamps to external acquisition hardware, enabling millisecond-scale alignment of behavior with two-photon imaging and electrophysiology. By lowering the cost and technical barriers to synchronized behavioral and neural recording, the NeuroHab makes multimodal, reproducible operant neuroscience accessible to a broad range of laboratories and adaptable to diverse experimental paradigms.

Light microscopy is one of the most powerful tools for understanding living systems, but the opacity of tissue prevents visualization of all but superficial layers. Several methods to clarify tissue have been developed, but most require fixed specimens. To address the challenge of improving resolution in functioning neuronal circuits, we developed a biocompatible clearing agent, iodixanol-ACSF, which is capable of increasing the transparency of living neuronal tissue. Brain-cleared mice were motile and unimpaired on a variety of behavioral tasks, and extracellular recordings showed that many cellular and circuit phenomena were well-preserved. In live iodixanol-ACSF cleared mouse brain tissue, both transmission and cellular-resolution fluorescence microscopy indicate improvements of 150-200% in penetration depth with one-third to one-half the laser intensity when compared to untreated tissue. Our results show that iodixanol-ACSF clearing will enable deeper imaging and extend our understanding of neuronal circuit function.

PurposePupil diameter in daily life depends on both the light reaching the eye and the observers age, but established prediction formulas require laboratory quantities that are rarely measured in natural environments. We developed a compact age-corrected model that predicts pupil diameter from melanopic equivalent daylight illuminance (mEDI). MethodsWe used an existing field dataset in which binocular pupil diameter and near-corneal spectral irradiance were recorded while 83 adults aged 18-87 years moved through indoor and outdoor environments. The analysis included 10,082 valid paired observations. We fitted a bounded sigmoid relating pupil diameter to mEDI and age, with each participant given equal influence, and assessed prediction in participants excluded from model fitting. Performance was compared with simpler models, a flexible generalised additive model (GAM), and Watson-Yellott predictions based on assumed field geometry. ResultsPupil diameter decreased smoothly as mEDI increased. Age primarily reduced the difference between pupils in dim and bright conditions, by 0.768 mm per decade, while the predicted bright-light diameter changed little with age. In held-out participants, the bounded model had a participant-balanced root mean squared error (RMSE) of 0.630 mm and mean absolute error of 0.537 mm. The GAM had a slightly lower point-estimate RMSE of 0.610 mm, but the difference was small and uncertain. The bounded model outperformed the tested log-linear, reduced, age-only, and Watson-Yellott alternatives. ConclusionAge and mEDI are sufficient to provide useful population-average pupil predictions across the observed adult age and real-world light range. The model is transparent, physiologically bounded, and nearly as accurate as a flexible GAM, but predictions approaching darkness remain uncertain because valid mEDI measurements were not available in that range. Key pointsO_LIA compact equation predicts population-average pupil diameter from age and mEDI alone. C_LIO_LIAge mainly compresses the pupils response range by reducing pupil diameter under dimmer conditions. C_LIO_LIPrediction error in unseen participants was close to that of a flexible GAM, without requiring a fitted smooth object. C_LIO_LIThe model is intended for the observed adult age and field-light range, not for extrapolation into darkness. C_LI

Abstract Background: Every non-invasive continuous glucose monitoring (NI-CGM) technology introduced into the landscape faces the same skeptical question, from regulators, clinicians, and competing developers alike: is the candidate signal actually specific to glucose, or does an apparently reasonable accuracy figure simply reflect a model fitting to motion, temperature, calibration offset, or trial-duration artifact? Existing evaluation practice does not answer this question directly. NI-CGM performance is instead reported almost exclusively with metrics inherited from minimally invasive, subcutaneous CGM, the Mean Absolute Relative Difference (MARD), Clarke/Parkes error grids, and ISO 15197-style agreement rates, which were designed for sensors whose glucose specificity is already chemically established and which therefore take specificity as a premise rather than treating it as a result to be demonstrated. Methods: We present a methodology for demonstrating NI-CGM technology glucose specificity during the algorithm-development phase, and illustrate it with a case study based on a quantum-cascade-laser (QCL) photoacoustic NI-CGM device (Neogly) evaluated in the SKAMo-2 free-living clinical trial (eight participants with type 1 diabetes). The methodology combines a white-noise control, a constant-glycemia control, a sensor-ablation control that removes the candidate physical signal while retaining auxiliary covariates, and explicit reporting of the train/test generalization level, so that a reported MARD can be read as evidence of specificity rather than taken on faith. Results: Removing the mid-infrared photoacoustic (PA) signal from the model while retaining all auxiliary sensors (accelerometer, skin temperature, hygrometry, PPG) degraded performance at every generalization level tested, inter-patient MARD rose from 35.0% with the PA signal to 43.1% without it, and intra-experimentation MARD rose from 22.5% to 23.9%, providing direct, internal evidence that the PA channel itself, and not merely the auxiliary covariates, carries glucose-specific information. At the same time, an algorithm trained on pure Gaussian noise produced a MARD of 25% over short test windows, and a trivial constant-glycemia predictor outperformed every machine-learning model tested when generalization was extended from a single recording to an unseen patient (MARD 55% for the naive constant model versus 37% for a deep neural network on inter-patient splits). Reported in isolation, any of these MARD values is uninterpretable; reported against one another, they jointly demonstrate that the signal is specific to glucose while also bounding how much of the headline accuracy figure that specificity currently explains. Conclusions: We propose a specificity-demonstration methodology for NI-CGM technology development, comprising (1) signal quality gating prior to any algorithm benchmarking, (2) a white-noise control to test for genuine information content, (3) a constant-glycemia control to expose trial-duration bias, (4) a sensor-ablation control that isolates the contribution of the candidate physical signal from auxiliary covariates, (5) explicit reporting of the data-splitting generalization level (intra-experimentation, intra-patient, inter-patient). This methodology answers a question that precedes clinical accuracy reporting and that recognized clinical frameworks such as the IFCC Working Group on CGM's Dynamic Glucose Regions guideline are not designed to answer: not how accurate is the device, but is the device measuring glucose at all. We argue that without these controls, MARD and error-grid values for NI-CGM are not comparable across studies and may either overstate clinical readiness or undermine promising technologies. We recommend that this specificity methodology be applied routinely once a candidate NI-CGM sensor reaches algorithm-development stage, alongside and as a deliberate complement to IFCC-style clinical accuracy reporting once the device is mature enough for that evaluation. Keywords: non-invasive continuous glucose monitoring; glucose specificity; algorithm validation; MARD; benchmarking; machine learning; photoacoustic spectroscopy; sensor ablation; Clarke error grid

Despite the growing use of functional near-infrared spectroscopy (fNIRS) hyperscanning to record brain activity simultaneously from interacting individuals in naturalistic settings, most analyses quantify functional connectivity separately for each channel pair. The resulting collection of pairwise estimates is difficult to integrate into a network-level characterization of intra- and inter-brain organization. Here, we present an open, configuration-driven Python toolkit that transforms preprocessed fNIRS hyperscanning time series into functional connectivity graphs. The toolkit constructs a bipartite inter-brain network for each dyad and separate intra-brain networks for each participant, computes node- and graph-level measures, and exports adjacency matrices, edge lists, analysis-ready summary tables, reproducibility metadata, and standardized visualizations. Dataset-specific parameters, including directory structure, participant naming, channel selection, epoch extraction, and edge-retention criteria, are defined in a human-readable YAML configuration file, enabling the same workflow to accommodate differently organized datasets without changes to the source code. We illustrate the pipeline using a representative recording from a mother-infant fNIRS hyperscanning dataset and present the resulting network outputs. The toolkit provides a reproducible framework for moving from pairwise functional connectivity estimates to network-level analyses of dyadic and individual brain organization.

Functional ultrasound imaging (fUSI) measures cerebral blood-volume responses, so anesthesia protocols developed for BOLD fMRI may not preserve its signal. We screened three fMRI-derived anesthesia regimens for visually evoked fUSI in the cat visual cortex. Isoflurane-ketamine-medetomidine produced the strongest and most consistent responses, but the standard intramuscular medetomidine bolus suppressed the signal in one sensitive cat. Pharmacokinetic modeling guided replacement of this bolus with controlled intravenous dosing, restoring the visual response while maintaining physiological stability. The same weight-based regimen produced robust responses in the other animals. In a direct within-session test, response strength was equivalent in recordings separated by more than three hours. Across 464 recordings from 51 sessions in three cats, it showed no temporal drift during follow-up extending to 23 months. Visually evoked activation also remained clear relative to a small awake dataset, although equivalence was not established. PK-guided control of medetomidine exposure therefore enables stable, repeated fUSI of the cat visual cortex over hours to years.

Investigating the consequences of astrocyte loss in the intact brain is both important and challenging. As integral components of the neuro-glia-vascular unit, astrocytes are involved in a variety of brain processes including water homeostasis, metabolic supply, regulation of cerebral blood flow, and coordination of neuronal circuit activity. Astrocyte impairment has been associated with numerous neurological disorders. However, experimental models combining focal astrocyte ablation with longitudinal in vivo imaging in the intact adult brain have been lacking, limiting efforts to define the causal contribution of astrocyte loss to central nervous system (CNS) pathology and repair. Here, we present an in vivo model of antibody-mediated astrocyte ablation that enables longitudinal imaging and detailed investigation of ensuing cellular responses. It integrates focal induction of aquaporin-4 antibody-mediated astrocyte loss, chronic in vivo two-photon imaging, genetically encoded sensors, and reporter mouse lines. This advancement allows visualization and quantification of cellular and subcellular events in living organisms during lesion progression and recovery. It overcomes many longstanding limitations of previous models that are either constrained by non-specific hypoxic or mechanical tissue damage or require sacrificing animals at discrete time points, hindering the ability to monitor dynamic biological processes over time. In contrast, the selective targeting of astrocytes prevents the formation of the glial border, enabling the investigation of CNS response in a scar-free environment. Overall, this new approach represents a significant technical advancement, enabling comprehensive longitudinal studies of CNS responses to astrocyte loss, thus opening new avenues for understanding astrocytopathy-driven pathology, evaluating therapeutic interventions, and promoting translational research.

Direct modulation of neural activity with high spatiotemporal precision is a cornerstone in experimental neuroscience. Here, we present a blood-mediated optoacoustic stimulation (BOAS) approach that utilizes blood as an endogenous transducer for brain stimulation. By delivering 532-nm nanosecond pulsed laser to the cortex, we demonstrate that the absorption of hemoglobin generates sufficient acoustic pressure to trigger neuronal activity. By integrating BOAS with calcium imaging in GCaMP6f-expressing mice, localized neuronal responses were observed. Quantitative analysis reveals that BOAS produces responses comparable to natural visual stimulation and is significantly more efficient than the photothermal stimulation. Furthermore, we show that the response is dose-dependent. At high energy doses, BOAS induces cortical spreading depression. Histological evaluation confirmed that the brain maintains tissue integrity even under these stimulation parameters. Together, this work establishes a versatile method for precise brain stimulation as an alternative method for stimulating neuron at cortex.

Spectroscopic single-molecule localization microscopy (sSMLM) enables multiplexed super-resolution imaging by simultaneously acquiring the spatial position and spectral information of individual fluorophores. Dual-wedge prism (DWP)-based implementations provide a compact, alignment-stable approach to spectral dispersion, but trade-offs between localization precision, spectral precision, and experimental complexity remain. We systematically compare five DWP-based sSMLM configurations, including two-dimensional (2D) and three-dimensional (3D) implementations using single DWP (DWP-sSMLM) and symmetrically-dispersed DWP (SDDWP-sSMLM). We evaluate lateral precision, spectral precision, and ease of use. SDDWP configurations acquire spectral images in both channels and utilize both for spatial localization, yielding the highest lateral and spectral precision. However, for applications that do not require axial information, 2D-DWP provides a simple, plug-and-play solution with robust performance. This work offers a guideline for selecting DWP configurations based on experimental needs.

Light reaching the retina is a primary regulator of human circadian physiology, acting largely through melanopsin-expressing retinal ganglion cells with peak short-wavelength sensitivity. Delivering known, repeatable retinal doses outside the laboratory is difficult because conventional light sources leave viewing geometry, gaze, and ambient conditions uncontrolled. Consumer extended-reality (XR) glasses fix a bright binocular display in constant geometry relative to the eye, but their suitability as calibrated photic stimulators has not been established. Here we validate a commercial micro-OLED XR display (VITURE Luma Ultra) for controlled retinal photostimulation. A purpose-built host application renders exact 8-bit RGB stimuli while independently controlling hardware brightness and logging all intensity-determining state; spectral radiance was measured at the retinal position of a 3D-printed phantom head with an open-source miniature spectroradiometer, anchored to absolute units by a luminance transfer calibration. The blue primary peaks at 461 nm (FWHM 43 nm), is spectrally invariant across a >10-fold intensity range, and at maximum output delivers an estimated 299 lx melanopic equivalent daylight illuminance, above consensus daytime recommendations, while remaining roughly two orders of magnitude below photobiological safety limits. The red primary is visually effective with minimal melanopic drive (melanopic DER 0.10), enabling spectrally shifted evening stimulation. Unlike the immersive virtual-reality headsets previously used for calibrated light delivery, the see-through form factor preserves the wearer's view of the surroundings--relevant for clinical monitoring in supervised settings such as the intensive care unit. These results show that consumer XR glasses can serve as a dose-calibrated platform for wearable photostimulation using an open-source measurement chain, and provide groundwork for application-layer dose-response studies.

BackgroundBrain regions integrate neural information arriving from several convergent projection sources. At the mesoscale level, neural projections can potentially span both hemispheres and extend along the entire rostrocaudal axis, which complicates efforts to map their full extent. To address this issue, we describe a novel method for mapping such mesoscale connectivity in vivo and ex vivo. Our neurotomographic approach utilizes micro-computed tomography (micro-CT) to image the spatial distribution of neural tracers bound to high Z-elements, e.g, gold. MethodsIn this study, we conjugated colloidal gold to a retrograde tracer wheat-germ agglutinin apo-horseradish peroxidase (WGA-HRP) and then stereotactically injected the gold-bound tracer (WAHG) into the mouse forebrain. Micro-CT was then used to image the brain in vivo and ex vivo, followed by three-dimensional reconstruction of tracer distribution. We then validated our approach by histologically processing the brains using silver enhancement to label gold particles; this enabled a direct comparison of histological labeling with the neurotomographic images. ResultsWe found that micro-CT imaging could reveal the major spatial distributions of the gold-bound tracer, which was consistent across in vivo and ex vivo imaging conditions. Moreover, the neurotomographically determined patterns corresponded with the labeling observed in histologically processed tissue, with the major sites of labeling reliably detected in reconstructed neurotomographic images. ConclusionsOverall, our findings demonstrate a potential novel method for non-destructive, three-dimensional mapping of neural tracers in vivo. This novel approach can potentially guide targeted multi-site recordings, enable validation of injection site placement, and facilitate rapid longitudinal connectomic analyses in vivo.

ObjectiveBiopotential measurement devices, such as EEG, ECG, and EMG recorders, are available in low-cost, open-source implementations with standard specifications. However, high-end systems remain expensive and predominantly proprietary, limiting accessibility and customization by research laboratories. In addition, neurophysiology techniques such as bioimpedance-based Fast Neural Electrical Impedance Tomography (FN-EIT) also rely on these systems for data acquisition. This work aimed to develop an open-source biopotential recording system using off-the-shelf components that achieves performance comparable to high-end devices. ApproachWe designed our system to provide simultaneous sampling over 32 channels, 24-bit resolution, 10 kHz bandwidth, 50 kHz sampling rate, and battery-powered operation while reducing cost by two orders of magnitude. System performance was evaluated comparatively against a reference device. Initial validation involved benchtop recordings in saline solution and standard non-invasive biopotential measurements (ECG and EMG). Further in-vivo validation was performed by recording evoked electrophysiological responses and FN-EIT traces from the sciatic nerve of a rat during tibial branch stimulation. Main resultsEMG recordings showed comparable RMS peak amplitudes (814{+/-}153 {micro}V vs. 897{+/-}113{micro}V, p=0.07), while ECG-derived heart rates closely matched between systems (64.8{+/-}4.0 bpm vs. 65.1{+/-}3.1bpm, p=0.54). During in-vivo recordings, compound action potentials exhibited comparable amplitudes and morphology (129{+/-}26 mV vs 128{+/-}25 mV, P=0.15). FN-EIT recordings showed strongly correlated baseline voltages (R>0.93, P=0.11), sub-microvolt noise levels (0.83{+/-}0.36{micro}V vs. 0.42{+/-}0.25{micro}V, p<0.05), and comparable impedance variations (0.006{+/-}0.002% vs 0.005{+/-}0.003, P>0.05). FN-EIT images of functional activity recorded with the novel device closely matched reference ones, exhibiting a 98.5% overlap in activated area. SignificanceThe proposed open-source device has the potential to broaden research access to customizable, high-specification data acquisition hardware and facilitate wider adoption of specialized neural recording techniques such as FN-EIT.

In populations with well-preserved cognitive function, cognitive screening total scores tend to cluster near the ceiling, making it difficult to characterize age-group differences from total scores alone. We compared the temporal structure of word production, acoustic features, and the magnitude and timing of forehead total-hemoglobin (total-Hb) responses during a phonemic verbal fluency task in adults in their 40s and 70s. A total of 254 healthy participants (115 in their 40s, 139 in their 70s) completed a 60-s phonemic verbal fluency task requiring words beginning with the Japanese syllable /ka/, administered as part of the Japanese version of the Montreal Cognitive Assessment (MoCA-J). We derived the total word count, word counts in 10-s bins, mean inter-word pause duration, speech offset time, smoothed cepstral peak prominence (CPPS), jitter, and shimmer. Area under the curve (AUC) and time-to-peak (TTP) were computed from forehead total-Hb signals recorded with a wearable single-wavelength near-infrared spectroscopy device. MoCA-J scores clustered near the ceiling in both groups, although the age-group difference was significant. The 70s group produced fewer words (14.00 vs 17.09) and showed longer inter-word pauses (1.60 vs 0.72 s). CPPS was lower, AUC was higher, and TTP was longer (32.97 vs 15.63 s) in the 70s group, whereas jitter did not differ. Word counts across 10-s bins showed an age group time-bin interaction. Within each age group, participants who produced more words showed longer TTP. Age-group differences in TTP and AUC persisted after adjustment for speech offset time (proportions mediated, 6.7% and 0.5%) and in a subsample matched on speech offset time. Even when screening scores clustered at the ceiling, the temporal structure of word production and forehead total-Hb responses differed between age groups, and these two classes of measures dissociated. Because the sample was selectively recruited and single-wavelength total-Hb signals do not index localized neural activity, the findings are descriptive and motivate longitudinal, multi-axis characterization of speech in aging.

Functional near-infrared spectroscopy (fNIRS) and functional magnetic resonance imaging (fMRI) both rely on the phenomenon of neurovascular coupling (NVC) to probe brain activity through their sensitivity to cerebral blood oxygenation. However, the relationship between fNIRS chromophores (oxy- and deoxyhaemoglobin, HbO and HbR), and fMRI (Blood Oxygen Level Dependent and Arterial Spin Labeling, BOLD and ASL) measurements, and whether this relationship remains consistent across subjects and physiological conditions, has only been partially characterised.. We acquired concurrent continuous-wave fNIRS and gradient-echo (GE) and spin-echo (SE) BOLD-ASL fMRI in healthy adults (n = 10) during visual stimulation. By applying calibrated fMRI methodology, we examined the relationships between fNIRS-derived haemoglobin modulations and fMRI-derived modulations in macrovascular (GE-) and microvascular (SE-) BOLD signals, cerebral blood flow (CBF), and oxygen metabolism (CMRO2). Group-level results showed strong temporal cross-modal agreement, with HbO and HbR tightly mirroring all fMRI signal time-courses (|r| > 0.8). A quantitative analysis of trial-by-trial modulations revealed distinct state-dependent behaviours: HbO maintained a stable relationship with the fMRI-derived metrics across conditions, whereas cross-modal relationships between HbR and fMRI-derived metrics substantially strengthened at higher flow-metabolism coupling (FMC), the ratio of CBF to CMRO2 change, an index of the strength of NVC. Both HbO and HbR were more strongly associated with GE-BOLD than with SE-BOLD. These findings provide a rigorous physiological grounding for fNIRS signal interpretation, demonstrating its utility as a surrogate marker for specific haemodynamic and metabolic parameters.

Radiation oncology has a long history of developing in-house health information technology (HIT) tools such as quality assurance (QA) checklists, yet there is little guidance from professional bodies on how to implement these tools in complex clinical environments. Building on our previous work that used human-centered participatory co-design, the Task-User-Representation-Function (TURF) framework, and multi-method usability evaluations to design and develop an enhanced dosimetry QA checklist (DQC), this study investigated the barriers and facilitators (determinants) to implementing the enhanced DQC in a radiation oncology clinic, examined implementation strategies, proposed an implementation framework for QA checklists in radiation oncology, and assessed four implementation outcomes: acceptability, appropriateness, feasibility, and adoption. We conducted a qualitative implementation study using an abductive research approach at an academic medical center. All key stakeholders (dosimetrists, physicists, trainees, and software developers) participated in semi-structured interviews, field observations, and surveys across pre-implementation, implementation, and post-implementation phases. Data were analyzed using a hybrid inductive-deductive approach, with deductive coding guided by an adapted Consolidated Framework for Implementation Research (CFIR) mapped to the Unified Theory of Acceptance and Use of Technology and by the Expert Recommendations for Implementing Change (ERIC) compilation. We identified 4 CFIR constructs and 12 sub-constructs as barriers, with structural characteristics and planning showing the highest negative valence, and 5 CFIR constructs and 19 sub-constructs as facilitators, with relative advantage, culture, and leadership engagement showing the highest positive valence. Participants' suggestions mapped to 19 ERIC strategies in 7 clusters, and the CFIR-ERIC matching tool identified 14 evidence-based strategies in 4 clusters that informed a proposed phased implementation framework. Acceptability, appropriateness, and feasibility scores improved significantly from pre-implementation to implementation for all professional roles (p<0.05), yet adoption reached 100% only in the sixth week of implementation. These findings highlight the value of combining subjective and objective implementation outcomes and provide a practical, evidence-based framework for implementing in-house QA checklists in radiation oncology that warrants validation in diverse settings.

BackgroundPhotobiomodulation (PBM) is an emerging non-invasive light-based brain stimulation technique that can alter cortical oscillations and is currently being pursued for improving cognition and treating neurological and psychiatric conditions. Nearly all human EEG evidence comes from transcranial PBM (tPBM) applied to the forehead, where light must traverse the scalp and thick skull, requiring protocols to compensate with high surface irradiance. Intranasal PBM (iPBM) can reach the anterior skull base at a fraction of that irradiance and has also been shown to modulate cerebrospinal fluid dynamics, yet it has been studied almost exclusively as an adjunct to tPBM, leaving its cortical effects in isolation, and its energy-efficiency relative to the transcranial route, unknown. ObjectiveTo define the spatiotemporal EEG response to pulsed iPBM delivered alone, determine whether stimulation parameters or individual biology moderate it, and compare the energy-efficiency of iPBM and tPBM in the same participants. MethodsHigh-density EEG was collected from forty-six healthy young adults during pulsed iPBM and tPBM spanning a parameter space of varying wavelengths, pulsation frequencies, and irradiances. Percent change in band power from a within-session pre-stimulation baseline was tested with spatiotemporal cluster-based permutation tests. Linear mixed-effects models with backward elimination assessed stimulation and biological moderators (sex, nostril-to-cortex distance). Energy-efficiency, defined as the percent change in band power per J/cm2 of delivered surface energy, was compared between routes within each subject in delivery route-specific cluster regions of interest (ROI) (Wilcoxon signed-rank tests, Benjamini-Hochberg false discovery rate). ResultsiPBM alone produced significant spatiotemporal clusters in theta, beta, and gamma power, with anterior increases and posterior decreases; no delta or alpha clusters survived correction. Beta and gamma effects appeared at stimulation onset and persisted even after stimulation ended, whereas theta effects strengthened after stimulation ended. No predictor survived elimination in any band, time window, or cluster ROI: response magnitude was independent of wavelength, pulsation frequency, irradiance, sex, and nostril-to-cortex distance. Notably, although iPBM delivered roughly twenty times less surface energy than tPBM ([~]0.6-1.1 vs [~]12-24 J/cm2), it produced EEG changes of similar magnitude, and its energy-efficiency exceeded that of tPBM in seven of eight eligible comparisons, with median iPBM-to-tPBM efficiency ratios of 14-32 (all FDR q<0.05) ConclusionsDelivered in isolation, pulsed iPBM elicits a robust cortical EEG signature closely resembling that of tPBM, is insensitive to the stimulation parameters and individual factors tested, and achieves this at a small fraction of the delivered surface energy. As a result, delivery route, not surface irradiance alone, should be treated as a primary variable in PBM dose reporting and protocol design.

Magnetoencephalography (MEG) offers non-invasive neuroimaging with high temporal and spatial precision - but its adoption is hampered by the prohibitive cost and infrastructure burden of a magnetically shielded room. We have overcome that burden and present a lightweight, low-cost, multichannel magnetoencephalography system that can image brain activity without needing a magnetically shielded room. The multichannel nature of the system facilitates not just detection but also localization of brain signals that are over 300 million times smaller than environmental interference, without requiring passive shielding. Our system weighs less than 75kg, more than 100 times lighter than a typical shielded room. This is made possible through low-cost active shielding and software-based spatial filtering. We also show that the signal to noise ratio of our in-vivo recordings is comparable to what can be obtained from a conventional cryogenically-cooled MEG system sited within a shielded room. This demonstration is a crucial step towards democratizing magnetoencephalography and making it a globally accessible neuroimaging technology for healthcare and discovery research.

Wearable magnetoencephalography (MEG) enabled by optically pumped magnetometers (OPMs) promises improved comfort and motion tolerance. This is particularly beneficial when measuring brain activity in children who cannot sit still for long periods of time. Compared to cryogenic MEG, wearable MEG allows larger head movements, but they result in artifacts due to uncompensated background fields and reduce source localization accuracy. Spatial filtering methods can partially compensate these motion-induced artifacts, but they are most effective when used in combination with background field nulling. This is because accurate spatial filtering relies on an accurate estimate of the sensor gain and orientation of its sensitive axis. Through simulations, we first deduce the target residual background field that is necessary for accurate dipole localization (< 1 cm) in the presence of head movements. Using our open-source printed circuit board (PCB) coils, we develop a method to dynamically null the background field. We demonstrate that our dynamic field nulling method allows improved localization of somatosensory evoked fields (SEFs) by maintaining the background field below the target residual fields established in the simulations. Our study highlights the importance of tracking both the background field and the head position relative to the background field for quality assurance in wearable MEG.

Microbubble-enhanced focused ultrasound (MB-FUS) enables noninvasive blood-brain barrier (BBB) opening to improve the delivery of drugs and other therapeutics to the brain, supporting more effective treatment of brain disorders. The benefits of this rapidly advancing and highly versatile technology have been demonstrated in clinical trials, sparking a growing interest in expanding FUS applications that require higher intensity treatments, larger targeted brain volumes and larger therapeutics. However, in-depth safety profiling of such treatments has not been done and is limited in the clinic. Preclinical studies have been restricted in their readouts, focusing on acute imaging and simple behaviors. To address the need for more holistic safety profiling, we present a novel preclinical workflow for determining adverse effects of MB-FUS in rats, both acutely and long-term, by combining MRI, histology, and a custom motor task which provides fine-scaled readouts for complex learned behavior. Using this approach and taking advantage of our previous delineation of the relevant circuitry, we show dose- and target-dependent adverse effects in high dosing regimens. All prescribed acoustic doses opened the BBB; but while low doses had no overt adverse effects, high doses targeting the involved circuitry had severe effects on both behavior and brain tissue integrity. These effects persisted for weeks and recovered over differing time courses, with tissue disruptions and behavioral changes outlasting general performance deficits. Our results reinforce the need for multimodal, highly sensitive, and longitudinal readouts to holistically characterize adverse effects of MB-FUS, allowing for its safe use across a wide range of applications. SignificanceMicrobubble-enhanced focused ultrasound is emerging as a powerful noninvasive approach for delivering drugs, genes, and cell therapies through the blood-brain barrier, sparking broad interest in expanding clinical and preclinical applications. However, its effects on complex neurological function, especially for higher dosing regimens, remain poorly defined. To address this, we have established a novel multimodal preclinical strategy for defining functional safety limits and guiding clinical translation, integrating sensitive behavioral testing with MRI, histology and acoustic emissions analysis. We show dose- and target-dependent impairments in complex learned motor behavior and evidence of possible brain injury, with substantially different recovery time courses. Together, our findings demonstrate the importance of a multimodal, longitudinal approach for comprehensively characterizing treatment-related adverse effects and evaluating safety.